Solvay Q1 2026 slides: margins hold amid 9% sales decline – Image for illustrative purposes only (Image credits: Pixabay)
Solvay reported underlying net sales of €997 million for the first quarter of 2026, down 8.5 percent organically from the same period a year earlier. The Belgian chemical company nevertheless delivered an underlying EBITDA margin of 21.9 percent, virtually unchanged from 22.3 percent in the prior year. One-off gains from litigation and carbon-emission rights helped offset weaker volumes and pricing pressure across key segments.
Resilient Performance in a Soft Market
The quarter reflected broad challenges in the chemical industry, including soft demand and pricing pressure, particularly in soda ash and Coatis. Performance Chemicals sales fell 13.9 percent, while the broader group saw volumes drop 3.3 percent and prices decline 5 percent. Currency and scope effects added further headwinds, bringing the reported sales decline to 11.1 percent. Yet the company protected profitability through disciplined cost control. Structural savings reached €22 million in the quarter, bringing the cumulative total since 2024 to €233 million. Additional support came from a €38 million optimization of the CO₂ portfolio and a €7 million litigation gain, both of which helped stabilize the bottom line.
Financial Snapshot
| Metric | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Underlying net sales | €997m | €1,122m | -11.1% (-8.5% organic) |
| Underlying EBITDA | €219m | €250m | -12.4% (-10.1% organic) |
| EBITDA margin | 21.9% | 22.3% | -0.4pp |
| Free cash flow | €26m | €42m | -37.4% |
Strategic Focus on Cash and Transformation
Management emphasized continued execution of its transformation plan even as external conditions remain difficult. The company reaffirmed its full-year 2026 guidance for underlying EBITDA between €770 million and €850 million, along with a free-cash-flow target of at least €200 million and capital expenditure capped at €300 million. Shares reacted negatively to the results, falling as much as 9 percent on the day of the release.
Outlook Remains Cautious
Solvay does not expect a quick rebound in market conditions and is prioritizing cash generation amid ongoing volatility. The first-quarter outcome demonstrates that the group’s cost discipline and portfolio optimization can cushion profitability even when top-line growth is elusive. Investors will watch closely for signs of demand stabilization in the coming quarters.